Kewaunee Scientific Corporation

Kewaunee Scientific Corporation

KEQU
Kewaunee Scientific CorporationUS flagNASDAQ Global Market
36.68
USD
+0.11
- -
105.29MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
42.62
45.25
48.23
51.22
58.11
53.45
53.65
53.43
60.61
77.72
70.77
84.02
- -
98.57
Basic EPS, GAAP
1.49
1.34
1.43
1.67
1.94
0.56
-1.7
-1.33
-2.2
0.26
6.51
3.98
- -
3.36
Free Cash Flow per Basic Share
3.09
0.87
2.73
4.31
1.17
0.91
1.51
0.33
-2.83
-1.34
6.8
5.17
- -
6.51
Dividend per Share
0.43
0.47
0.51
0.58
0.66
0.74
0.38
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
14.82
15.6
16.33
17.21
18.63
18.39
16.26
14.88
12.56
12.69
19.03
23.16
- -
26.55
Tangible Book Value per Share
13.12
13.4
14.46
15.99
17.72
17.4
14.07
15.03
12.99
13.63
19.52
12.55
- -
16.79
Basic Weighted Avg Shares
3
3
3
3
3
3
3
3
3
3
3
3
- -
3
Sales/Revenue/Turnover
111
119
129
139
158
147
148
147
169
219
204
240
282
282
Operating Margin (%)
5.36
4.4
4.43
4.72
6.28
1.44
-1.59
-0.89
-1.54
2.44
8.97
7.39
5.93
5.93
Depreciation Expense
3
3
3
3
3
3
3
3
3
3
3
5
6
6
Net Income, GAAP
4
4
4
5
5
2
-5
-4
-6
1
19
11
10
10
Effective Tax Rate (%)
33.13
32.4
32.44
31.51
43.26
20.9
- -
- -
- -
69.79
- -
21.66
23.8
23.8
Profit Margin (%)
3.5
2.97
2.96
3.26
3.34
1.04
-3.18
-2.49
-3.63
0.34
9.2
4.74
3.41
3.41
Working Capital
27
28
30
33
37
33
27
26
49
48
56
65
57
57
LT Debt
4
4
3
2
1
- -
8
8
6
7
6
43
21
21
Total Equity
34
35
39
43
48
48
39
41
36
38
56
66
77
77
Return on Invested Capital (%)
9.31
8.22
8.54
9.34
10.81
2.97
- -
- -
- -
3.37
- -
15.25
11.46
11.46
Return on Capital (%)
8.33
7.49
7.72
8.75
9.47
2.78
- -
- -
- -
1.35
- -
14.82
10.35
10.35
Return on Common Equity (%)
10.2
8.87
9
10.02
10.86
3.02
-9.85
-8.56
-16.11
2.08
41.38
18.84
13.52
13.52

Capital Structure

FRC

in mil. unless spec.
Oct'26
Jan'26
Apr'26
ST Debt
7
10
9
LT Borrowings
32
16
15
LT Finance Leases
8
7
7
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3
3
3
Market Capitalization
120
113
106

Working Capital

FRC

in mil. unless spec.
Oct'26
Jan'26
Apr'26
Total Current Assets
114
104
105
Cash, Cash Equivalents & STI
13
8
10
Accounts Receivable, Net
59
54
59
Inventories
35
33
31
Total Current Liabilities
46
49
48
Payables & Accruals
26
27
26
ST Debt
7
10
9
Deferred Revenue
4
4
4

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.44%
14.69%
15.95%
Free Cash Flow
-167.62%
-326.22%
26.04%
Net Income, GAAP
187.75%
468.2%
-15.67%
Sales/Revenue/Turnover
8.77%
14.52%
17.27%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
50
50
47
57
204
2025
48
48
67
77
240
2026
71
70
69
71
282

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.87
0.94
0.87
3.86
6.51
2025
0.77
1.05
0.47
1.7
3.98
2026
1.08
0.85
0.24
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Thomas David Hull
Full Time Employees
1,006
Sector
Consumer Cyclical
Industry
Furnishings, Fixtures & Appliances
Address
2700 West Front Street Statesville NC United States of America 28677-2927
IPO Date
Mar 17, 1980
Business
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture products, serving global markets. Its core product portfolio includes steel, wood, and laminate casework; laboratory fume hoods; adaptable modular systems; moveable workstations; stand-alone benches; biological safety cabinets; epoxy resin work surfaces and sinks; and associated fittings and fixtures. The company also offers educational furniture and specialized safety cabinets tailored to life sciences, healthcare, and research environments. Founded in 1906 and headquartered in Statesville, North Carolina, Kewaunee operates three manufacturing facilities in Statesville and one facility in Bangalore, India, with sales offices in the United States, India, Saudi Arabia, and Singapore. A major recent development for Kewaunee Scientific is the acquisition of Nu Aire, a Minneapolis-based manufacturer known for biological safety cabinets, CO2 incubators, ultralow freezers, animal handling equipment, pharmacy compounding isolators, and related laboratory products. Completed in 2024 for $55 million, this acquisition expands Kewaunee’s product range and geographic reach, especially across Asia, Africa, and the Middle East, where Nu Aire maintains distribution partnerships. The acquisition strengthens Kewaunee's capabilities in laboratory and biosafety solutions, enabling the company to deliver more comprehensive and diversified laboratory outfitting options to a broader global customer base. Kewaunee’s products and services support laboratory environments in life sciences, petrochemical, education, government, and healthcare sectors. Its technical furniture line includes workstations, workbenches, computer enclosures, and network storage systems. The company continues to invest in innovation and operational expansion to meet evolving laboratory needs worldwide, leveraging its newly enhanced product suite and global distribution network following recent strategic initiatives and acquisitions.

Company News

APIChatGPT
  • Kewaunee Scientific Q4 Earnings & Sales Fall Y/Y on Project Timing

  • Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter

  • Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter

  • Kewaunee Scientific (NASDAQ:KEQU) Stock Crosses Below Two Hundred Day Moving Average – Time to Sell?

  • Kewaunee Scientific (NASDAQ:KEQU) Stock Price Crosses Below 200-Day Moving Average – Time to Sell?

  • Kewaunee Scientific Corporation Appoints Jorge Santos as Vice President of International Sales, Laboratory Products Group

  • Kewaunee Earnings Decline Y/Y in Q3 Despite Sales Growth

  • Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2026

  • Kewaunee Scientific and Nu Aire Inc. to Attend analytica 2026 in Munich

  • Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2026

  • Thomas David Hull III Sells 884 Shares of Kewaunee Scientific (NASDAQ:KEQU) Stock

  • Kewaunee's Net Sales Increase Y/Y, Earnings Decline in Q2

  • Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2026

  • Kewaunee Scientific Announces Successful Debt Refinancing and Full Repayment of Seller Notes From the Company's Acquisition of Nu Aire, Inc.

  • Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2026

  • Kewaunee Scientific Q1 Earnings Rise Y/Y, Stock Slides 19%

  • Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2026

  • Kewaunee Scientific to Attend the 2025 Arablab Live Trade Show in Dubai

  • Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2026

  • Kewaunee Upgraded to Outperform on Nu Aire Synergies, Backlog